BioCryst Pharmaceuticals
BCRX
#4741
Rank
NZ$3.89 B
Marketcap
NZ$15.24
Share price
3.20%
Change (1 day)
20.45%
Change (1 year)

Earnings for BioCryst Pharmaceuticals (BCRX)

Earnings in 2026 (TTM): -NZ$0.67 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's current earnings are NZ$0.94 Billion. In 2025 the company made an earning of NZ$0.47 Billion, an increase over its 2024 earnings that were of -NZ$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioCryst Pharmaceuticals from 1994 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.67 Billion-239.18%
2025 NZ$0.47 B-407.51%
2024 -NZ$0.16 Billion-61.56%
2023 -NZ$0.41 Billion-7.43%
2022 -NZ$0.44 Billion34.42%
2021 -NZ$0.33 Billion-0.55%
2020 -NZ$0.33 Billion67.88%
2019 -NZ$0.2 Billion7.55%
2018 -NZ$0.19 Billion53.92%
2017 -NZ$0.12 Billion19.29%
2016 -NZ$98.26 Million28.19%
2015 -NZ$76.65 Million-4.8%
2014 -NZ$80.52 Million50.09%
2013 -NZ$53.65 Million-23.29%
2012 -NZ$69.94 Million-26.19%
2011 -NZ$94.75 Million54.78%
2010 -NZ$61.22 Million150.1%
2009 -NZ$24.48 Million-49.43%
2008 -NZ$48.4 Million14.07%
2007 -NZ$42.43 Million-49.31%
2006 -NZ$83.71 Million72.87%
2005 -NZ$48.43 Million22.08%
2004 -NZ$39.67 Million75.3%
2003 -NZ$22.63 Million-25.36%
2002 -NZ$30.32 Million225.05%
2001 -NZ$9.33 Million-56.6%
2000 -NZ$21.49 Million50.63%
1999 -NZ$14.27 Million38.05%
1998 -NZ$10.34 Million-52.46%
1997 -NZ$21.74 Million58.44%
1996 -NZ$13.72 Million-14.44%
1995 -NZ$16.04 Million28.57%
1994 -NZ$12.48 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
-NZ$3.49 Billion 412.87%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$14.05 B-2,169.72%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-NZ$0.24 Billion-65.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
NZ$0.13 B-119.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-NZ$0.4 Billion-41.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.59 Billion-14.52%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-NZ$14.42 Million-97.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-NZ$39.66 Million-94.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-NZ$0.17 Billion-75.05%๐Ÿ‡บ๐Ÿ‡ธ USA